Natco Pharma to raise stake in Adcock Ingram to 49 percent for Rs 1,069 cr

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

NATCOPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.7%Reaction day

₹983.15

prior close

₹977.40

announcement price

In-mkt

timing

Nifty Smallcap 250market-2.0%+0.3% vs market

Pharmaceuticals peers, median of 165sector-0.8%-0.9% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Smallcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

-0.2

15m

+0.1

30m

+1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.7-2.0+0.3-0.8-0.9

Next day

-2.2-0.4-1.8+0.0-2.2

+0.0+0.9-0.9+0.6-0.6

-0.4+1.2-1.6+1.0-1.4

-1.1+0.1-1.3+0.2-1.3

-1.4+0.8-2.2+1.0-2.4

-3.9+0.3-4.2-0.3-3.6

15d

-4.7+0.1-4.9-0.3-4.4

-7.3+2.2-9.5-0.1-7.2

-16.1+3.2-19.3+3.1-19.2

-19.2-2.6-16.6-1.5-17.7

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Natco Pharma board approved investing up to Rs 1,400 cr in its South African wholly-owned subsidiary and acquiring an additional 13.25 percent stake in Adcock Ingram Holdings for about Rs 1,069 cr, raising its holding from 35.75 percent to 49 percent. Adcock Ingram, a South African pharma firm with turnover of ZAR 9,760 million in FY25, will contribute 49 percent of its profits to Natco post-deal. Transaction expected to close by end of July 2026.

Likely market impact

Positive strategic move expanding African footprint; capital deployment of about Rs 1,069 cr may pressure short-term cash flows but boosts long-term earnings.